Shares Of Pluristem Therapeutics Surging Following Receipt Of Orphan Drug Designation
December 31, 2015 at 10:20 AM EST
Shares Pluristem Therapeutics Inc. (NASDAQ: PSTI), a biotherapeutics company that develops off-the-shelf allogeneic cell therapy ...